Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prosicca sine is a preservative-free ophthalmic lubricant indicated for the symptomatic treatment of dry eye syndrome (keratoconjunctivitis sicca). The active ingredient is hypromellose (hydroxypropyl methylcellulose), a semi-synthetic, viscoelastic polymer that functions as an artificial tear. By increasing the viscosity of the tear film, hypromellose enhances tear stability and prolongs the residence time of the solution on the ocular surface, providing relief from irritation and dryness. The "sine" formulation is specifically designed without the preservative benzalkonium chloride, making it suitable for patients with hypersensitivity to preservatives or those requiring frequent daily applications. It is developed and marketed by OmniVision.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hypromellose (OmniVision).